Cyclacel Pharmaceuticals, Inc. (CYCC)
NASDAQ: CYCC · IEX Real-Time Price · USD
1.720
+0.040 (2.38%)
At close: Jul 26, 2024, 3:59 PM
1.710
-0.010 (-0.58%)
After-hours: Jul 26, 2024, 5:19 PM EDT

Cyclacel Pharmaceuticals Revenue

Cyclacel Pharmaceuticals had revenue of $29.00K in the quarter ending March 31, 2024. This brings the company's revenue in the last twelve months to $449.00K. In the year 2023, Cyclacel Pharmaceuticals had annual revenue of $420.00K.

Revenue (ttm)
$449.00K
Revenue Growth
n/a
P/S Ratio
5.54
Revenue / Employee
$37,417
Employees
12
Market Cap
2.49M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023420.00K--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
cbdMD 21.58M
InMed Pharmaceuticals 5.63M
Tenon Medical 3.21M
Helius Medical Technologies 668.00K
FOXO Technologies 139.00K
Aclarion 60.05K
Heart Test Laboratories 18.60K
Revenue Rankings